Evaluation of NMU-Induced Breast Cancer Treated with Sirolimus and Sunitinib on Breast Cancer Growth.
Nurul Fathiyatul Nabila JaffarMuhammad Shahidan Muhammad SakriHasnan JaafarWan Faiziah Wan Abdul RahmanTengku Ahmad Damitri Al Astani Bin Tengku DinPublished in: Asian Pacific journal of cancer prevention : APJCP (2020)
Sirolimus is neither synergistic nor additive with sunitinib for breast cancer treatment.<br />.